| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |